Kelley L Coffman-D'Annibale (Kelley Coffman-D'Annibale)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Topics

Randomized Controlled Trial

Liver Metastases

Top Venues

Journal for immunotherapy of cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Kelley L Coffman-D'Annibale, Tim F Greten
Top advances of the year: Hepatobiliary cancers. Cancer 129 (8) (2023)
Kelley L Coffman-D'Annibale, Tim F Greten
Top advances of the year: Hepatobiliary cancers. Cancer (2023)
Kelley L Coffman-D'Annibale, Tim F Greten
Top advances of the year: Hepatobiliary cancers. Cancer 129 (8) (2023)